IoMT Risk Assessment Frameworks

If you manage connected medical devices, one framework is not enough. In many U.S. hospitals, 50%–75% of connected assets are medical or IoT devices, which means risk work has to cover patient safety, PHI, vendor risk, and device lifecycle at the same time.

If I had to boil this article down fast, here’s the answer:

• Use NIST CSF 2.0 for enterprise governance
• Use IEC 80001-1 for devices on clinical networks
• Use IoMT-SAF for pre-purchase scoring
• Use TARA for product threat modeling and FDA premarket work
• Use ISO/IEC 27001 + 27005 as the governance layer around the program, not as the device method

You also need to judge each option by four simple questions:

• Does it fit IoMT and clinical use?
• Does it line up with HIPAA, FDA Section 524B, and QMSR?
• Does it cover the full device lifecycle, from purchase to retirement?
• Does it help with supplier and SBOM risk?

A few points stand out right away:

• NIST CSF 2.0 is the best starting point for health systems
• IEC 80001-1 is strong when network connection can affect safety and care delivery
• IoMT-SAF is built for side-by-side vendor review before deployment
• TARA is strongest early, when teams are mapping attacker paths and design risk
• ISO/IEC 27001 + 27005 helps formalize risk decisions, but it does not go deep enough on device security by itself

Navigating the World of IoMT Cybersecurity

sbb-itb-535baee

Quick Comparison

So my takeaway is simple: pick a stack, not a single framework. Start with governance, add device and network-specific methods, and keep assessments current as devices, software, and vendors change.

1. NIST Cybersecurity Framework (CSF)

NIST CSF is the broadest framework in this comparison, which makes it the best place to start for IoMT risk management. NIST CSF 2.0, released in 2024, now extends to IoT and OT, so it works well as a baseline for IoMT risk work.

"The Functions, Categories, and Subcategories apply to all ICT used by an organization, including information technology (IT), the Internet of Things (IoT), and operational technology (OT)." - NIST ^[4]

IoMT Coverage

CSF 2.0 is built around six functions: Govern, Identify, Protect, Detect, Respond, and Recover. For IoMT, that structure is practical.

Identify helps teams build a solid device inventory. Protect supports segmentation, which matters a lot for devices that can't be patched on demand. Detect helps spot unusual behavior. Respond and Recover help keep clinical systems available when something goes wrong. Profiles and Tiers also help organizations compare their current state to a target posture, which is useful when older devices are still in service ^[4].

NIST SP 800-213, finalized in early 2025, applies these ideas more directly to medical devices. It also deals with a very real issue in healthcare: FDA validation requirements can slow patching, even when a risk is known ^[5].

Regulatory Alignment

CSF 2.0 lines up well with HIPAA and FDA cybersecurity expectations ^[4][3]. NIST SP 800-213 also helps organizations line up with the FDA's Quality Management System Regulation (QMSR), which takes effect on February 2, 2026, and incorporates ISO 13485:2016 ^[5].

It also works alongside HHS 405(d) Health Industry Cybersecurity Practices (HICP). In plain terms, CSF gives healthcare teams a usable way to organize and apply those recommendations.

Lifecycle Support

The framework supports the full device lifecycle, not just day-to-day security operations.

During procurement, NIST SP 800-213 recommends checking a manufacturer's cybersecurity maturity and asking for proof of vulnerability disclosure procedures and patch timelines ^[5]. For implementation, the guidance covers asset management, FIPS 140-2 compliant encryption, and network segmentation ^[5].

Monitoring is meant to be continuous, not something done every few months and forgotten. And when devices reach end of life, decommissioning should be planned under the FDA-recommended SPDF ^[2][5].

Third-Party Risk Support

The Govern function in CSF 2.0 directly covers supply chain cybersecurity. That gives healthcare organizations a clear way to set IoMT vendor-risk policies from the procurement stage forward ^[4].

NIST SP 800-213 adds more detail by calling for vendor maturity assessments and ongoing surveillance of third-party components through a Software Bill of Materials ^[5][2]. That broad scope is the main strength of CSF; the frameworks that follow go deeper on device-specific and control-level detail.

2. ISO/IEC 27001 with ISO/IEC 27005

Where NIST CSF gives you a broad operating structure, ISO/IEC 27001 and ISO/IEC 27005 work together to put formal governance around information security risk. In practice, they set up a repeatable, ISMS-based way to document security risk decisions. Organizations can streamline this by using automated security questionnaires to map responses directly to these frameworks.

IoMT Coverage

These standards are strongest at the ecosystem level. They cover cloud backends, update servers, and data flows into the EHR ^[1][6].

The boundary is pretty plain: ISO/IEC 27001 and 27005 don't deal with the tight limits of embedded medical systems or the secure-by-design engineering work IoMT devices need. Unlike NIST CSF, which spans operating controls across the device lifecycle, ISO/IEC 27001/27005 governs the organization around IoMT, not the devices themselves. So the pair works best as a governance layer, not as a device-security method.

Regulatory Alignment

ISO/IEC 27001 can help support alignment with EU MDR Annex I and the FDA's Quality Management System Regulation (QMSR) ^[7]. But it isn't the main medical-device cybersecurity benchmark.

IEC 81001-5-1 is the closer product-security reference for health software, and ISO/IEC 27001 by itself does not meet FDA Section 524B or EU MDR device-security expectations on its own.

Use it next to device-specific standards. A practical way to do that is:

• Apply ISO/IEC 27001 to the organizational parts of the FDA's Secure Product Development Framework, especially post-market vulnerability handling and incident response.
• Pair it with medical-device standards for product-level requirements.

Lifecycle Support

ISO/IEC 27001 helps with post-market vulnerability monitoring and incident response. What it does not spell out is threat modeling, software composition analysis, or coordinated vulnerability disclosure.

If you want lifecycle coverage from development through maintenance, pair it with IEC 62304 or IEC 81001-5-1. That gap stands out even more when device-and-network safety is the main issue.

Third-Party Risk Support

ISO/IEC 27001 includes controls for supplier relationship management, which gives healthcare organizations a clear way to assess third-party cloud providers and software vendors. It supports vendor assessment processes, but it does not require machine-readable Software Bills of Materials (SBOMs) in formats like CycloneDX or SPDX. That's a key gap for supply-chain transparency and FDA Section 524B requirements ^[3][6].

This is where the next framework picks up the slack by dealing more directly with shared-network risk at the clinical system level.

3. IEC 80001-1

Where ISO/IEC 27001 focuses on the organization, IEC 80001-1 focuses on the risk that shows up when medical devices connect to clinical networks.

In plain English: it deals with risk management before, during, and after a medical device is connected to health IT infrastructure. The 2021 edition lines up with ISO 31000 and puts risk into three buckets: safety, effectiveness, and security. Here, effectiveness means the network can support the intended patient-care outcome.

IoMT Coverage

IEC 80001-1 covers connected devices, the software and hardware that support them, and the workflows built around them. It applies in hospitals, laboratories, and clinical offices where those parts work together to diagnose, monitor, or treat patients ^[10].

It also treats organizational reputation as part of health IT infrastructure ^[10]. That matters in hospital-owned networks, where device safety often depends on shared systems rather than a single standalone product.

Regulatory Alignment

FDA recognizes IEC 80001-1 for connected-system risk management, and its Security and Confidentiality controls can also help with HIPAA support ^[11][12]. In the EU, Notified Bodies often expect manufacturers to provide network requirements and security characteristics that line up with this standard ^[9].

Lifecycle Support

IEC 80001-1 applies across the connected system lifecycle, from planning through decommissioning ^[8][10]. It calls for risk analysis workshops that bring together clinical staff, IT administrators, and outside suppliers so teams can spot shared-network risks before and after go-live ^[10].

### Third-Party Vendor Risk Management Support

The standard uses Responsibility Agreements to spell out roles among Healthcare Delivery Organizations (HDOs), device manufacturers, and IT service providers ^[9]. Manufacturers are also expected to support the process with security disclosures, often through the MDS2 form ^[9].

The 80001 series also includes supporting technical reports. For example:

• TR 80001-2-2 covers security disclosure
• TR 80001-2-8 covers security capabilities

These documents give teams more direction for day-to-day use ^[9]. That shared-responsibility model is especially helpful during procurement and go-live decisions. This is critical because the economic impact of third-party risk can be severe if vendor-related breaches occur.

4. IoMT-SAF (Internet of Medical Things Security Assessment Framework)

IoMT-SAF is narrower than the frameworks above. It focuses on procurement-stage risk decisions. In plain English, it helps teams score an IoMT solution before deployment against a defined clinical scenario. That makes it a good fit when a team needs an objective purchase-time score, not a broad governance program.

IoMT-SAF helps close the vendor-adopter trust gap by giving healthcare teams a way to verify device security before purchase. Instead of taking vendor claims at face value, adopters can test those claims against a structured framework ^[13].

IoMT Coverage

IoMT-SAF looks at endpoints, gateways, and cloud platforms, then maps security controls to the deployment scenario ^[13]. It uses 260 attributes, but only the ones tied to the scenario in front of the team are applied ^[13].

Regulatory Alignment

IoMT-SAF can adjust to new regulatory inputs, including FDA Section 524B requirements for SBOMs and cybersecurity planning ^[1][13].

Lifecycle Support

This framework is at its best during procurement and selection. In practice, it supports pre-deployment scoring for solution selection ^[13]. It is built for point-in-time evaluation, not for patch management or incident management over time ^[13][15].

That difference matters. If a team wants help choosing between vendors, IoMT-SAF gives them a structured way to do it. If the goal is day-to-day security operations after rollout, it won’t cover enough on its own. That’s why it pairs well with approaches that follow the full device lifecycle.

Third-Party Risk Support

Its main strength is quantitative, scenario-based third-party risk vendor comparison ^[13]. Teams can use it to compare vendors in the context that matters most: the actual clinical use case.

The trade-off is the setup work. Those 260 attributes can mean a lot of manual input ^[13][14]. So the payoff is depth at the evaluation stage, while the weak spot is support for security work after selection.

5. TARA-Based IoMT Risk Assessment Approaches

TARA - Threat Assessment and Risk Analysis - starts with attacker paths. Instead of working from a control checklist, it asks a more direct question: how could a real attacker go after a specific device architecture, and what weaknesses would that path expose?

That shift matters. TARA is not a procurement-stage scoring method. It's a manufacturer-side approach used to shape design risk before release and then revisit that risk after launch. In connected medical devices, teams now use it to study attacker paths across connected device architectures. It relies on DFDs and STRIDE to map trust boundaries and entry points before manufacture ^[17][1].

IoMT Coverage

TARA should cover more than the device itself. It needs to include update servers, cloud backends, companion apps, and the deployment environment, because all of them add to the attack surface ^[1][2].

A device used at home doesn't face the same threats as one sitting inside a hospital network. That's a big deal in IoMT, and TARA is built to reflect that difference.

Regulatory Alignment

STRIDE is recognized by the FDA and the EU MDCG 2019-16 framework as an acceptable threat modeling approach ^[1]. Under Section 524B, missing threat models or SBOMs can block submission ^[1].

TARA outputs should also connect to the ISO 14971 safety risk file. Cybersecurity risk assessment needs to feed that file, since that's where patient harm and risk acceptability are judged. In plain terms, teams can't stop at technical impact. They need to describe cyber threats in patient harm terms if they want to support compliance and patient safety.

Lifecycle Support

TARA has the most value early in design, especially during system requirements work. That's the point where it can shape architecture choices and security requirements before changes get expensive ^[16].

Regulators also expect threat models to act as living artifacts. They should be updated when designs change, when new weaknesses appear in third-party components, or when post-market surveillance surfaces new risks ^[1]. That ties SBOM accuracy and supplier tracking to the same risk process.

Third-Party Risk Support

TARA should track third-party and open-source risk through the SBOM, then cross-check those components against CISA's KEV catalog. In FDA reviews, an outdated SBOM - or no SBOM at all - is often a submission blocker ^[1][18].

Its main strength is design-time threat modeling. Its main limit is day-to-day operational risk management.

Side-by-Side Analysis by Decision Factors

No framework wins every category. The tables below boil the earlier details down to four decision factors: device fit, regulatory fit, lifecycle fit, and vendor risk. Together, these criteria show where each framework works well and where it has gaps.

IoMT Coverage

For procurement decisions, IEC 80001-1 and TARA-based approaches stand out on device fit. By contrast, NIST CSF 2.0 and ISO/IEC 27001 with 27005 need a fair amount of tailoring before they map cleanly to clinical environments.

Regulatory Alignment

For U.S. healthcare organizations, regulatory alignment means support for HIPAA, FDA Section 524B, and QMSR. NIST CSF 2.0 leads on governance for HDOs, while TARA-based approaches and IoMT-SAF are the strongest fit for FDA premarket compliance.

Lifecycle Support

If day-to-day continuity matters most, IEC 80001-1 and IoMT-SAF offer the most complete lifecycle support. TARA, on the other hand, is strongest during design and needs extra coverage once the device is deployed.

Third-Party Risk Support

For supplier oversight, IoMT-SAF leads with its focus on components and SBOM transparency. ISO/IEC 27001 with 27005 is weaker here, especially when you need more depth on medical device suppliers. And if you're dealing with a large vendor portfolio, Censinet RiskOps™ helps streamline third-party risk assessments across clinical applications, medical devices, and supply chains.

Pros and Cons

The table below gives you a fast, choose-by-use-case view.

The biggest gap across all of these frameworks shows up after deployment. A one-time assessment might look fine on paper, but that doesn't keep risk data current as devices, vendors, and apps change.

That’s where operational follow-through matters. Risk artifacts need regular updates, not a set-it-and-forget-it approach. Censinet RiskOps™ helps healthcare organizations keep device, vendor, and application risk assessments current without manual overhead. This approach is critical for effectively managing third-party risk across the enterprise.

Conclusion

IoMT risk management works best as a layered program. So the decision isn't just about picking ONE framework. It's about giving each framework a clear job.

Start with an enterprise framework such as NIST CSF 2.0 for governance or ISO/IEC 27001 for formal risk management. Then add device-specific controls. In plain terms, build the enterprise layer first, and then add device and network standards wherever connected medical devices create day-to-day risk.

After those layers are in place, the hard part is keeping risk data current. Organization size, device volume, and regulatory scope will shape how many layers you need and how fast you put them in place.

Assessments also need to stay current as devices, vendors, and applications change. That's the common failure point across all frameworks. For organizations that want to cut manual work tied to keeping risk data current, Censinet RiskOps™ supports collaborative third-party and enterprise risk assessments across devices, applications, and supply chains. In IoMT, the framework stack matters less than keeping it up to date.

FAQs

Which IoMT risk framework should we start with?

For healthcare organizations, the NIST Cybersecurity Framework (CSF) 2.0 is a strong place to begin when managing IoMT risk. It gives you a clear, flexible structure that also lines up well with healthcare compliance needs like HIPAA.

From there, you can add more focused frameworks based on what you need. Use STRIDE or PASTA for technical threat modeling and device-level assessments, and the Secure Product Development Framework (SPDF) for medical device development.

Why isn’t one framework enough for IoMT risk management?

No single framework covers all of IoMT risk management. Each one leans in a different direction, whether that's technical threats, organizational governance, or product-level security.

That’s why many healthcare organizations use more than one framework. It helps them deal with both regulatory demands and the day-to-day reality of clinical settings.

Censinet RiskOps™ supports this work by bringing compliance, PHI tracking, and vendor risk management into one platform built for healthcare.

How do these frameworks help with SBOM and vendor risk?

These frameworks strengthen SBOM and vendor risk management by putting clear rules around governance, purchasing, and day-to-day oversight. For example, NIST Cybersecurity Framework 2.0 helps organizations assess device manufacturers, spell out security expectations, and ask vendors for attestations during procurement.

They also make it easier to bring SBOMs into risk assessment workflows. That way, teams can spot CVEs as known risks that need fixes or design updates. Standards such as IEC 62304 also support review of vendor documentation, including SBOMs and traceability matrices.

Related Blog Posts

• NIST CSF vs IoT Device Risks in Healthcare
• EU MDR Guidance for IoT Device Risk Assessments
• NIST CSF Tiers: IoT Device Maturity Explained
• NIST CSF vs. Other IoT Risk Frameworks